Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Frontiers in Immunology|August 30, 2024
Antigen-specific T cell responses in autoimmune diabetesAlexander J Dwyer, Zachary R Shaheen, Brian T FifeCurrent Diabetes Reports|May 6, 2021
The Role of Programmed Death-1 in Type 1 DiabetesChristopher G Tucker, Alexander J Dwyer, Brian T Fife, et al.Human Vaccines & Immunotherapeutics|June 26, 2015
Randomized phase II trial of docetaxel with or without PSA-TRICOM vaccine in patients with castrate-resistant metastatic prostate cancer: A trial of the ECOG-ACRIN cancer research group (E1809)Douglas G McNeel, Yu-Hui Chen, James L Gulley, et al.Scientific Reports|August 26, 2021
Enhanced CD4+ and CD8+ T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progressesAlexander J Dwyer, Jacob M Ritz, Jason S Mitchell, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2020
Adoptive T Cell Therapy with IL-12-Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for AutoimmunityChristopher G Tucker, Jason S Mitchell, Tijana Martinov, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2019
Programmed Death-1 Restrains the Germinal Center in Type 1 DiabetesTijana Martinov, Linnea A Swanson, Elise R Breed, et al.Biorxiv : the Preprint Server for Biology|March 3, 2023
Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetesJustin A Spanier, Vivian Fung, Christine M Wardell, et al.The Journal of Clinical Investigation|August 10, 2023
Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in miceJustin A Spanier, Vivian Fung, Christine M Wardell, et al.Immunity|August 30, 2024
CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetesJason S Mitchell, Justin A Spanier, Alexander J Dwyer, et al.Nature Metabolism|August 20, 2019
Increased β-cell proliferation before immune cell invasion prevents progression of type 1 diabetesErcument Dirice, Sevim Kahraman, Dario F De Jesus, et al.Pageof 1